Nieuwenhuis, S.; Widomska, J.; Blom, P.; ‘t Hoen, P.-B.A.C.; van Engelen, B.G.M.; Glennon, J.C.; on behalf of the OPTIMISTIC Consortium.
Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1). Int. J. Mol. Sci. 2022, 23, 3081.
https://doi.org/10.3390/ijms23063081
AMA Style
Nieuwenhuis S, Widomska J, Blom P, ‘t Hoen P-BAC, van Engelen BGM, Glennon JC, on behalf of the OPTIMISTIC Consortium.
Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1). International Journal of Molecular Sciences. 2022; 23(6):3081.
https://doi.org/10.3390/ijms23063081
Chicago/Turabian Style
Nieuwenhuis, Sylvia, Joanna Widomska, Paul Blom, Peter-Bram A. C. ‘t Hoen, Baziel G. M. van Engelen, Jeffrey C. Glennon, and on behalf of the OPTIMISTIC Consortium.
2022. "Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)" International Journal of Molecular Sciences 23, no. 6: 3081.
https://doi.org/10.3390/ijms23063081
APA Style
Nieuwenhuis, S., Widomska, J., Blom, P., ‘t Hoen, P.-B. A. C., van Engelen, B. G. M., Glennon, J. C., & on behalf of the OPTIMISTIC Consortium.
(2022). Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1). International Journal of Molecular Sciences, 23(6), 3081.
https://doi.org/10.3390/ijms23063081